Senate bill · S. 5059 (119th Congress)
Amend the Public Health Service Act to streamline the review of biosimilar biological products
Official titleShow
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
The heading above is this same sentence with its legal opening removed. No words were added, changed or reordered.
U.S. Senate
Summary
Would amend the Public Health Service Act provision governing FDA review of applications for biosimilar biological products by striking one subparagraph and renumbering the one that follows it.
AI summary. Not an official summary. How we handle summaries
From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data
Following needs an Agora account. You will sign in first, then come back to this page.
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate
Cosponsors
Angela D. Alsobrooks, Lisa Blunt Rochester and 1 other
Cosponsors listed on Congress.gov, shown A to Z.
- Democratic2
- Republican1
This bill has cosponsors from more than one party.
Shown in neutral colors by design; Agora is non-partisan.
Full history
- Jul 21, 2026
Introduced
Introduced in U.S. Senate
U.S. Senate
- Jul 21, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jul 21, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jul 21, 2026
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.